Serum Paraoxonase Levels in Type 2 Diabetes Mellitus Patients: A Case-Control Study

Serum Paraoxonase Levels in Type 2 Diabetes Mellitus Patients: A Case-Control Study

Background and Objectives: Diabetes, a lifelong progressive disease, with metabolic dysregulation, is associated with increased risk of cardiovascular complications. Paraoxonase (PON), an enzyme associated with high-density lipoprotein (HDL) is known to modulate the antioxidant and anti-inflammatory...

Full description

Bibliographic Details
Main Authors:	D Namitha, Aliya Nusrath, A Rajeshwari, N Asha Rani
Format:	Article
Language:	English
Published:	ADICHUNCHANAGIRI INSTITUTE OF MEDICAL SCIENCES 2015-06-01
Series:	Journal of Medical Sciences and Health
Subjects:	dyslipidemia thiobarbituric acid reacting substances paraoxonase type 2 diabetes mellitus
Online Access:	http://jmsh.ac.in/index.php?option=com_k2&view=item&id=16:serum-paraoxonase-levels-in-type-2-diabetes-mellitus-patients-a-case-control-study&Itemid=70

Similar Items

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
by: Sunil K Kota, et al.
Published: (2013-01-01)

The Effect of Eicosapentaenoic Acid on the Serum Levels and Enzymatic Activity of Paraoxonase 1 in the Patients With Type 2 Diabetes Mellitus
by: Mohammad Hassan Golzari, et al.
Published: (2017-10-01)

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
by: Y. Atamer, et al.
Published: (2013-01-01)

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
by: Y. Atamer, et al.
Published: (2013-06-01)

Serum values of glutathione, paraoxonase and myeloperoxidase in women with gestational diabetes mellitus compared with normal pregnant women in Khorramabad during 2014-2015
by: Ali Khosrowbeygi, et al.
Published: (2017-10-01)

Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents
by: Moushira Erfan Zaki, et al.
Published: (2014-01-01)

Paraoxonase-1 activity in type 2 diabetes mellitus with and without nephropathy
by: Nehal H El-said, et al.
Published: (2015-01-01)

Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients
by: Mehrdad Solati, et al.
Published: (2012-10-01)

Paraoxonase 1 gene (Gln192–Arg) polymorphism and the risk of coronary artery disease in type 2 diabetes mellitus
by: Mohamed Fahmy Elnoamany, et al.
Published: (2012-06-01)

Paraoxonase 1 gene polymorphisms in patients with type 2 diabetes mellitus
by: M. V. Kim, et al.
Published: (2014-06-01)

Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats
by: Daniela Fernandes Roxo, et al.
Published: (2019-04-01)

Q192R paraoxonase gene 1 (PON1) polymorphism and atorvastatin therapy effect in patients with type 2 diabetes mellitus (T2DM)
by: M. V. Kim, et al.
Published: (2015-03-01)

Serum Antioxidative Enzymes Levels and Oxidative Stress Products in Children and Adolescents with Type I Diabetes Mellitus
by: Özlem Akgün, et al.
Published: (2018-09-01)

The effect of Omega-3 fatty acids on serum paraoxonase activity, vitamins A, E, and C in type 2 diabetic patients
by: Anis Kouchak, et al.
Published: (2011-01-01)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
by: Angelo Zinellu, et al.
Published: (2023-07-01)

Paraoxonase 1 activity is associated with interleukin-6 levels in type 2 diabetes: Effects of age and gender
by: Armin Nikzad, et al.
Published: (2023-01-01)

Correlation of serum adiponectin and leptin levels in obesity and Type 2 diabetes mellitus
by: Arundhati G Diwan, et al.
Published: (2018-01-01)

Evaluation of dyslipidemia in type 2 diabetes mellitus
by: Devendra Pratap Singh Rajput
Published: (2015-05-01)

Activity of serum paraoxonase 1, lipid profile and atherogenic indexes in diabetic induced rats treated with alpha lipoic acid
by: Parisa Jamor, et al.
Published: (2018-10-01)

Effect of Packaging Method and Storage Time on Physicochemical Characteristics of Dry-Cured Pork Neck Products at 10°C
by: Il-Suk Kim, et al.
Published: (2014-11-01)

Serum resistin and adiponectin relationships with glucometabolic control in patients with type 2 diabetes mellitus
by: Al Regaeiy Khlalid A., et al.
Published: (2018-01-01)

Investigation of Serum Paraoxonase 1 (PON1) Activities in Postprandial Lipemia
by: Yahya Altınkaynak, et al.
Published: (2019-04-01)

Comparison of Total Oxidative Stress, Total Antioxidant Capacity, and Paraoxonase, Arylesterase, and Lipid Peroxidase Levels in Aqueous Humor and Serum of Diabetic and Non-Diabetic Patients with Catarac
by: Cengiz Caner, et al.
Published: (2012-01-01)

Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study
by: Szu Han Lin, et al.
Published: (2018-04-01)

Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
by: Valentina Rosta, et al.
Published: (2020-07-01)

Profile of type 2 diabetes mellitus without overt complications of diabetes mellitus at a tertiary care center
by: Rajiv Singla, et al.
Published: (2012-01-01)

Paraoxonase 1 Phenotype and Paraoxonase Activity in Asthmatic Patients
by: Nurhan Sarioglu, et al.
Published: (2015-02-01)

Paraoxonase gene polymorphisms: Understanding the biochemical and genetic basis of coronary artery disease
by: Fathima J. Nasreen, MD, et al.
Published: (2023-04-01)

Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis
by: Aytac Atamer, et al.
Published: (2014-01-01)

Phytochemicals as Modulators of Paraoxonase-1 in Health and Diseases
by: Zahra Najafi Arab, et al.
Published: (2022-06-01)

Serum arylesterase and paraoxonase activities in patients with ovarian tumors
by: Slawomir Michalak, et al.
Published: (2014-12-01)

Evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy
by: Ayan Durmu§, et al.
Published: (2019-01-01)

Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial
by: Guilherme Balsan, et al.
Published: (2019-01-01)

Effective variant of type 2 diabetes mellitus treatment
by: I.V. Cherniavska, et al.
Published: (2018-03-01)

Disturbance of Arginase Activity and Nitric Oxide Levels in Iraqi Type 2 Diabetes Mellitus
by: Baghdad Science Journal
Published: (2018-06-01)

Caffeine Increases Apolipoprotein A-1 and Paraoxonase-1 but not Paraoxonase-3 Protein Levels in Human-Derived Liver (HepG2) Cells
by: Gülben Sayılan Özgün, et al.
Published: (2017-12-01)

Recent dyslipidemia guidelines for patients with diabetes mellitus
by: Eun-Jung Rhee
Published: (2020-12-01)

The Effect of Exercise on Paraoxonase-1 Activity and Lipid Profile in Obesity and Insulin Resistance Conditions
by: Hoseyn Fatolahi, et al.
Published: (2017-06-01)

Dyslipidemia in type 2 diabetes mellitus
by: Stefanović Aleksandra, et al.
Published: (2019-01-01)

THE INFLUENCE OF DYSLIPIDEMIA ON THE PERIODONTAL STATUS IN TYPE 2 DIABETES MELLITUS PATIENTS
by: Amelia Surdu, et al.
Published: (2015-01-01)